IL-6, a cytokine with many roles, is typically present in a range of tumor microenvironments and has been associated with tumor development and therapeutic resistance across multiple cancer types, primarily through its modulation of the immune system [38, 39]. The gene discussed is IL6; the disease is neoplasm.